Effect of rovatirelin in patients with cerebellar ataxia: two randomised double-blind placebo-controlled phase 3 trials

OBJECTIVE: To investigate the efficacy of rovatirelin, a thyrotropin-releasing hormone analogue, for ataxias in patients with spinocerebellar degeneration (SCD). METHODS: Two multicentre, randomised, double-blind, placebo-controlled phase 3 studies (KPS1301, KPS1305) enrolled patients with predomina...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishizawa, Masatoyo, Onodera, Osamu, Hirakawa, Akihiro, Shimizu, Yoshitaka, Yamada, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Neurodegeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035688/
https://www.ncbi.nlm.nih.gov/pubmed/31937586
http://dx.doi.org/10.1136/jnnp-2019-322168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035688/
https://www.ncbi.nlm.nih.gov/pubmed/31937586
http://dx.doi.org/10.1136/jnnp-2019-322168

Ejemplares similares